nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—ALB—type 2 diabetes mellitus	0.142	1	CbGaD
Ceftriaxone—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.0552	0.0876	CbGbCtD
Ceftriaxone—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0492	0.0781	CbGbCtD
Ceftriaxone—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0475	0.0755	CbGbCtD
Ceftriaxone—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0438	0.0696	CbGbCtD
Ceftriaxone—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0424	0.0673	CbGbCtD
Ceftriaxone—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0418	0.0664	CbGbCtD
Ceftriaxone—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0378	0.0599	CbGbCtD
Ceftriaxone—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.036	0.0572	CbGbCtD
Ceftriaxone—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0283	0.0448	CbGbCtD
Ceftriaxone—ALB—Gliclazide—type 2 diabetes mellitus	0.0262	0.0417	CbGbCtD
Ceftriaxone—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0262	0.0416	CbGbCtD
Ceftriaxone—ALB—Repaglinide—type 2 diabetes mellitus	0.0247	0.0392	CbGbCtD
Ceftriaxone—SLC15A1—Glyburide—type 2 diabetes mellitus	0.0243	0.0386	CbGbCtD
Ceftriaxone—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0233	0.0371	CbGbCtD
Ceftriaxone—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0206	0.0327	CbGbCtD
Ceftriaxone—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0199	0.0315	CbGbCtD
Ceftriaxone—ALB—Valsartan—type 2 diabetes mellitus	0.0182	0.0289	CbGbCtD
Ceftriaxone—ALB—Nateglinide—type 2 diabetes mellitus	0.0169	0.0268	CbGbCtD
Ceftriaxone—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0134	0.0213	CbGbCtD
Ceftriaxone—SLC22A6—Losartan—type 2 diabetes mellitus	0.0123	0.0195	CbGbCtD
Ceftriaxone—ALB—Glyburide—type 2 diabetes mellitus	0.0114	0.0181	CbGbCtD
Ceftriaxone—ALB—Losartan—type 2 diabetes mellitus	0.0104	0.0166	CbGbCtD
Ceftriaxone—GLUL—peripheral nervous system—type 2 diabetes mellitus	0.00368	0.145	CbGeAlD
Ceftriaxone—GLUL—islet of Langerhans—type 2 diabetes mellitus	0.00139	0.0547	CbGeAlD
Ceftriaxone—GLUL—retina—type 2 diabetes mellitus	0.00119	0.0468	CbGeAlD
Ceftriaxone—SLC22A11—nephron tubule—type 2 diabetes mellitus	0.00118	0.0464	CbGeAlD
Ceftriaxone—GLUL—nephron tubule—type 2 diabetes mellitus	0.00112	0.0441	CbGeAlD
Ceftriaxone—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.00111	0.0438	CbGeAlD
Ceftriaxone—SLC22A11—kidney—type 2 diabetes mellitus	0.00104	0.0408	CbGeAlD
Ceftriaxone—SLC22A11—cortex of kidney—type 2 diabetes mellitus	0.00101	0.0397	CbGeAlD
Ceftriaxone—GLUL—cardiovascular system—type 2 diabetes mellitus	0.001	0.0396	CbGeAlD
Ceftriaxone—GLUL—kidney—type 2 diabetes mellitus	0.000983	0.0387	CbGeAlD
Ceftriaxone—GLUL—pancreas—type 2 diabetes mellitus	0.000976	0.0385	CbGeAlD
Ceftriaxone—GLUL—cortex of kidney—type 2 diabetes mellitus	0.000957	0.0377	CbGeAlD
Ceftriaxone—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000951	0.0375	CbGeAlD
Ceftriaxone—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.000924	0.0364	CbGeAlD
Ceftriaxone—GLUL—adipose tissue—type 2 diabetes mellitus	0.000886	0.0349	CbGeAlD
Ceftriaxone—SLC15A1—kidney—type 2 diabetes mellitus	0.000812	0.032	CbGeAlD
Ceftriaxone—Cefazolin—PON1—type 2 diabetes mellitus	0.000792	0.468	CrCbGaD
Ceftriaxone—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000665	0.0262	CbGeAlD
Ceftriaxone—SLC22A11—liver—type 2 diabetes mellitus	0.000655	0.0258	CbGeAlD
Ceftriaxone—GLUL—liver—type 2 diabetes mellitus	0.000621	0.0245	CbGeAlD
Ceftriaxone—SLC15A2—retina—type 2 diabetes mellitus	0.000614	0.0242	CbGeAlD
Ceftriaxone—SLC22A8—kidney—type 2 diabetes mellitus	0.000584	0.023	CbGeAlD
Ceftriaxone—SLC15A2—nephron tubule—type 2 diabetes mellitus	0.000578	0.0228	CbGeAlD
Ceftriaxone—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000569	0.0224	CbGeAlD
Ceftriaxone—SLC15A1—liver—type 2 diabetes mellitus	0.000513	0.0202	CbGeAlD
Ceftriaxone—SLC15A2—kidney—type 2 diabetes mellitus	0.000508	0.02	CbGeAlD
Ceftriaxone—SLC15A2—cortex of kidney—type 2 diabetes mellitus	0.000495	0.0195	CbGeAlD
Ceftriaxone—ALB—liver—type 2 diabetes mellitus	0.000385	0.0152	CbGeAlD
Ceftriaxone—Cefotetan—ALB—type 2 diabetes mellitus	0.00024	0.142	CrCbGaD
Ceftriaxone—Cefpiramide—ALB—type 2 diabetes mellitus	0.000209	0.124	CrCbGaD
Ceftriaxone—Cefonicid—ALB—type 2 diabetes mellitus	0.000182	0.108	CrCbGaD
Ceftriaxone—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000162	0.00112	CcSEcCtD
Ceftriaxone—Nausea—Repaglinide—type 2 diabetes mellitus	0.000162	0.00112	CcSEcCtD
Ceftriaxone—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000161	0.00112	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000161	0.00111	CcSEcCtD
Ceftriaxone—Flushing—Irbesartan—type 2 diabetes mellitus	0.00016	0.00111	CcSEcCtD
Ceftriaxone—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00016	0.00111	CcSEcCtD
Ceftriaxone—Pruritus—Glipizide—type 2 diabetes mellitus	0.000159	0.00111	CcSEcCtD
Ceftriaxone—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000159	0.0011	CcSEcCtD
Ceftriaxone—Flatulence—Metformin—type 2 diabetes mellitus	0.000157	0.00109	CcSEcCtD
Ceftriaxone—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000156	0.00108	CcSEcCtD
Ceftriaxone—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000156	0.00108	CcSEcCtD
Ceftriaxone—Malaise—Orlistat—type 2 diabetes mellitus	0.000156	0.00108	CcSEcCtD
Ceftriaxone—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000156	0.00108	CcSEcCtD
Ceftriaxone—Chills—Irbesartan—type 2 diabetes mellitus	0.000155	0.00108	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000155	0.00108	CcSEcCtD
Ceftriaxone—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000155	0.00107	CcSEcCtD
Ceftriaxone—Palpitations—Valsartan—type 2 diabetes mellitus	0.000155	0.00107	CcSEcCtD
Ceftriaxone—Infection—Gliclazide—type 2 diabetes mellitus	0.000155	0.00107	CcSEcCtD
Ceftriaxone—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000154	0.00107	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000154	0.00107	CcSEcCtD
Ceftriaxone—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000154	0.00107	CcSEcCtD
Ceftriaxone—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000154	0.00107	CcSEcCtD
Ceftriaxone—Palpitations—Orlistat—type 2 diabetes mellitus	0.000153	0.00106	CcSEcCtD
Ceftriaxone—Renal failure—Ramipril—type 2 diabetes mellitus	0.000153	0.00106	CcSEcCtD
Ceftriaxone—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000153	0.00106	CcSEcCtD
Ceftriaxone—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000153	0.00106	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000152	0.00106	CcSEcCtD
Ceftriaxone—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000151	0.00105	CcSEcCtD
Ceftriaxone—Jaundice—Ramipril—type 2 diabetes mellitus	0.000151	0.00105	CcSEcCtD
Ceftriaxone—Flushing—Losartan—type 2 diabetes mellitus	0.000151	0.00105	CcSEcCtD
Ceftriaxone—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000151	0.00105	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00015	0.00104	CcSEcCtD
Ceftriaxone—Convulsion—Orlistat—type 2 diabetes mellitus	0.00015	0.00104	CcSEcCtD
Ceftriaxone—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00015	0.00104	CcSEcCtD
Ceftriaxone—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00015	0.00104	CcSEcCtD
Ceftriaxone—Dizziness—Glipizide—type 2 diabetes mellitus	0.000149	0.00103	CcSEcCtD
Ceftriaxone—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000149	0.00103	CcSEcCtD
Ceftriaxone—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000148	0.00103	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000148	0.00103	CcSEcCtD
Ceftriaxone—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000148	0.00102	CcSEcCtD
Ceftriaxone—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000147	0.00102	CcSEcCtD
Ceftriaxone—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000147	0.00102	CcSEcCtD
Ceftriaxone—Discomfort—Orlistat—type 2 diabetes mellitus	0.000146	0.00101	CcSEcCtD
Ceftriaxone—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000145	0.00101	CcSEcCtD
Ceftriaxone—Malaise—Metformin—type 2 diabetes mellitus	0.000144	0.000999	CcSEcCtD
Ceftriaxone—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000144	0.000998	CcSEcCtD
Ceftriaxone—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000143	0.000995	CcSEcCtD
Ceftriaxone—Vomiting—Glipizide—type 2 diabetes mellitus	0.000143	0.000994	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000143	0.000992	CcSEcCtD
Ceftriaxone—Oedema—Valsartan—type 2 diabetes mellitus	0.000143	0.000992	CcSEcCtD
Ceftriaxone—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000143	0.000991	CcSEcCtD
Ceftriaxone—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000143	0.00099	CcSEcCtD
Ceftriaxone—Infection—Valsartan—type 2 diabetes mellitus	0.000142	0.000986	CcSEcCtD
Ceftriaxone—Rash—Glipizide—type 2 diabetes mellitus	0.000142	0.000985	CcSEcCtD
Ceftriaxone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000142	0.000985	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000142	0.000984	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000141	0.000981	CcSEcCtD
Ceftriaxone—Oedema—Orlistat—type 2 diabetes mellitus	0.000141	0.000981	CcSEcCtD
Ceftriaxone—Headache—Glipizide—type 2 diabetes mellitus	0.000141	0.000979	CcSEcCtD
Ceftriaxone—Palpitations—Metformin—type 2 diabetes mellitus	0.000141	0.000978	CcSEcCtD
Ceftriaxone—Infection—Orlistat—type 2 diabetes mellitus	0.00014	0.000974	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.00014	0.000972	CcSEcCtD
Ceftriaxone—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00014	0.00097	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.00014	0.00097	CcSEcCtD
Ceftriaxone—Flatulence—Losartan—type 2 diabetes mellitus	0.00014	0.000969	CcSEcCtD
Ceftriaxone—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000139	0.000966	CcSEcCtD
Ceftriaxone—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000139	0.000964	CcSEcCtD
Ceftriaxone—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000139	0.000963	CcSEcCtD
Ceftriaxone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000138	0.000961	CcSEcCtD
Ceftriaxone—Agitation—Irbesartan—type 2 diabetes mellitus	0.000138	0.00096	CcSEcCtD
Ceftriaxone—Urticaria—Glyburide—type 2 diabetes mellitus	0.000138	0.000956	CcSEcCtD
Ceftriaxone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000137	0.000951	CcSEcCtD
Ceftriaxone—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000137	0.000951	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000137	0.000948	CcSEcCtD
Ceftriaxone—Malaise—Irbesartan—type 2 diabetes mellitus	0.000136	0.000942	CcSEcCtD
Ceftriaxone—Headache—Pioglitazone—type 2 diabetes mellitus	0.000135	0.000938	CcSEcCtD
Ceftriaxone—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000135	0.000935	CcSEcCtD
Ceftriaxone—Discomfort—Metformin—type 2 diabetes mellitus	0.000134	0.000931	CcSEcCtD
Ceftriaxone—Nausea—Glipizide—type 2 diabetes mellitus	0.000134	0.000928	CcSEcCtD
Ceftriaxone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000134	0.000927	CcSEcCtD
Ceftriaxone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000133	0.000924	CcSEcCtD
Ceftriaxone—Pain—Gliclazide—type 2 diabetes mellitus	0.000133	0.000924	CcSEcCtD
Ceftriaxone—Rash—Glimepiride—type 2 diabetes mellitus	0.000132	0.00092	CcSEcCtD
Ceftriaxone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000132	0.000919	CcSEcCtD
Ceftriaxone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000132	0.000917	CcSEcCtD
Ceftriaxone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000132	0.000916	CcSEcCtD
Ceftriaxone—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000132	0.000916	CcSEcCtD
Ceftriaxone—Headache—Glimepiride—type 2 diabetes mellitus	0.000132	0.000914	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000131	0.000912	CcSEcCtD
Ceftriaxone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000131	0.000911	CcSEcCtD
Ceftriaxone—Anaemia—Losartan—type 2 diabetes mellitus	0.000131	0.000909	CcSEcCtD
Ceftriaxone—Agitation—Losartan—type 2 diabetes mellitus	0.00013	0.000904	CcSEcCtD
Ceftriaxone—Oedema—Metformin—type 2 diabetes mellitus	0.00013	0.000904	CcSEcCtD
Ceftriaxone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00013	0.0009	CcSEcCtD
Ceftriaxone—Flushing—Ramipril—type 2 diabetes mellitus	0.000129	0.000899	CcSEcCtD
Ceftriaxone—Infection—Metformin—type 2 diabetes mellitus	0.000129	0.000898	CcSEcCtD
Ceftriaxone—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000128	0.000891	CcSEcCtD
Ceftriaxone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000128	0.00089	CcSEcCtD
Ceftriaxone—Malaise—Losartan—type 2 diabetes mellitus	0.000128	0.000887	CcSEcCtD
Ceftriaxone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000128	0.000886	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000127	0.000885	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000127	0.000883	CcSEcCtD
Ceftriaxone—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000127	0.00088	CcSEcCtD
Ceftriaxone—Leukopenia—Losartan—type 2 diabetes mellitus	0.000127	0.00088	CcSEcCtD
Ceftriaxone—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000127	0.000879	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000126	0.000874	CcSEcCtD
Ceftriaxone—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000126	0.000874	CcSEcCtD
Ceftriaxone—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000125	0.00087	CcSEcCtD
Ceftriaxone—Palpitations—Losartan—type 2 diabetes mellitus	0.000125	0.000869	CcSEcCtD
Ceftriaxone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000125	0.000866	CcSEcCtD
Ceftriaxone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000124	0.000864	CcSEcCtD
Ceftriaxone—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000124	0.000863	CcSEcCtD
Ceftriaxone—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000124	0.000858	CcSEcCtD
Ceftriaxone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000123	0.000854	CcSEcCtD
Ceftriaxone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000123	0.000854	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000123	0.000853	CcSEcCtD
Ceftriaxone—Oedema—Irbesartan—type 2 diabetes mellitus	0.000123	0.000853	CcSEcCtD
Ceftriaxone—Pruritus—Glyburide—type 2 diabetes mellitus	0.000123	0.000851	CcSEcCtD
Ceftriaxone—Infection—Irbesartan—type 2 diabetes mellitus	0.000122	0.000847	CcSEcCtD
Ceftriaxone—Pain—Orlistat—type 2 diabetes mellitus	0.000121	0.000839	CcSEcCtD
Ceftriaxone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000121	0.000837	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.00012	0.000835	CcSEcCtD
Ceftriaxone—Rash—Bromocriptine—type 2 diabetes mellitus	0.00012	0.00083	CcSEcCtD
Ceftriaxone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000119	0.000829	CcSEcCtD
Ceftriaxone—Discomfort—Losartan—type 2 diabetes mellitus	0.000119	0.000827	CcSEcCtD
Ceftriaxone—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000119	0.000826	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000119	0.000824	CcSEcCtD
Ceftriaxone—Headache—Bromocriptine—type 2 diabetes mellitus	0.000119	0.000824	CcSEcCtD
Ceftriaxone—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000119	0.000823	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000117	0.000811	CcSEcCtD
Ceftriaxone—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000117	0.000811	CcSEcCtD
Ceftriaxone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000116	0.000808	CcSEcCtD
Ceftriaxone—Oedema—Losartan—type 2 diabetes mellitus	0.000116	0.000803	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000116	0.000803	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000115	0.000802	CcSEcCtD
Ceftriaxone—Infection—Losartan—type 2 diabetes mellitus	0.000115	0.000797	CcSEcCtD
Ceftriaxone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000115	0.000796	CcSEcCtD
Ceftriaxone—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000115	0.000795	CcSEcCtD
Ceftriaxone—Urticaria—Valsartan—type 2 diabetes mellitus	0.000114	0.000788	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000113	0.000786	CcSEcCtD
Ceftriaxone—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000113	0.000784	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000113	0.000782	CcSEcCtD
Ceftriaxone—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000113	0.000782	CcSEcCtD
Ceftriaxone—Urticaria—Orlistat—type 2 diabetes mellitus	0.000112	0.000779	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000112	0.000776	CcSEcCtD
Ceftriaxone—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000112	0.000775	CcSEcCtD
Ceftriaxone—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000112	0.000775	CcSEcCtD
Ceftriaxone—Agitation—Ramipril—type 2 diabetes mellitus	0.000112	0.000775	CcSEcCtD
Ceftriaxone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00011	0.000766	CcSEcCtD
Ceftriaxone—Vomiting—Glyburide—type 2 diabetes mellitus	0.00011	0.000765	CcSEcCtD
Ceftriaxone—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00011	0.000764	CcSEcCtD
Ceftriaxone—Malaise—Ramipril—type 2 diabetes mellitus	0.00011	0.00076	CcSEcCtD
Ceftriaxone—Rash—Glyburide—type 2 diabetes mellitus	0.000109	0.000758	CcSEcCtD
Ceftriaxone—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000109	0.000758	CcSEcCtD
Ceftriaxone—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000109	0.000755	CcSEcCtD
Ceftriaxone—Headache—Glyburide—type 2 diabetes mellitus	0.000109	0.000754	CcSEcCtD
Ceftriaxone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000108	0.000751	CcSEcCtD
Ceftriaxone—Palpitations—Ramipril—type 2 diabetes mellitus	0.000107	0.000745	CcSEcCtD
Ceftriaxone—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000107	0.000745	CcSEcCtD
Ceftriaxone—Cefoperazone—ALB—type 2 diabetes mellitus	0.000107	0.0634	CrCbGaD
Ceftriaxone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000106	0.000739	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000106	0.000739	CcSEcCtD
Ceftriaxone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000105	0.000731	CcSEcCtD
Ceftriaxone—Convulsion—Ramipril—type 2 diabetes mellitus	0.000105	0.000731	CcSEcCtD
Ceftriaxone—Pain—Irbesartan—type 2 diabetes mellitus	0.000105	0.000729	CcSEcCtD
Ceftriaxone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000104	0.000722	CcSEcCtD
Ceftriaxone—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000104	0.000721	CcSEcCtD
Ceftriaxone—Urticaria—Metformin—type 2 diabetes mellitus	0.000103	0.000718	CcSEcCtD
Ceftriaxone—Nausea—Glyburide—type 2 diabetes mellitus	0.000103	0.000714	CcSEcCtD
Ceftriaxone—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000103	0.000714	CcSEcCtD
Ceftriaxone—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000103	0.000714	CcSEcCtD
Ceftriaxone—Discomfort—Ramipril—type 2 diabetes mellitus	0.000102	0.000709	CcSEcCtD
Ceftriaxone—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000102	0.000706	CcSEcCtD
Ceftriaxone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000101	0.000703	CcSEcCtD
Ceftriaxone—Pruritus—Valsartan—type 2 diabetes mellitus	0.000101	0.000702	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.0001	0.000697	CcSEcCtD
Ceftriaxone—Pruritus—Orlistat—type 2 diabetes mellitus	9.99e-05	0.000694	CcSEcCtD
Ceftriaxone—Oedema—Ramipril—type 2 diabetes mellitus	9.91e-05	0.000688	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.91e-05	0.000688	CcSEcCtD
Ceftriaxone—Vomiting—Gliclazide—type 2 diabetes mellitus	9.89e-05	0.000687	CcSEcCtD
Ceftriaxone—Pain—Losartan—type 2 diabetes mellitus	9.89e-05	0.000686	CcSEcCtD
Ceftriaxone—Rash—Gliclazide—type 2 diabetes mellitus	9.81e-05	0.000681	CcSEcCtD
Ceftriaxone—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.8e-05	0.00068	CcSEcCtD
Ceftriaxone—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.78e-05	0.000679	CcSEcCtD
Ceftriaxone—Urticaria—Irbesartan—type 2 diabetes mellitus	9.76e-05	0.000677	CcSEcCtD
Ceftriaxone—Headache—Gliclazide—type 2 diabetes mellitus	9.75e-05	0.000677	CcSEcCtD
Ceftriaxone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.71e-05	0.000674	CcSEcCtD
Ceftriaxone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.71e-05	0.000674	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.71e-05	0.000674	CcSEcCtD
Ceftriaxone—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.66e-05	0.000671	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.58e-05	0.000665	CcSEcCtD
Ceftriaxone—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.53e-05	0.000661	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.45e-05	0.000656	CcSEcCtD
Ceftriaxone—Dizziness—Valsartan—type 2 diabetes mellitus	9.45e-05	0.000656	CcSEcCtD
Ceftriaxone—Dizziness—Orlistat—type 2 diabetes mellitus	9.34e-05	0.000648	CcSEcCtD
Ceftriaxone—Nausea—Gliclazide—type 2 diabetes mellitus	9.24e-05	0.000642	CcSEcCtD
Ceftriaxone—Pruritus—Metformin—type 2 diabetes mellitus	9.21e-05	0.000639	CcSEcCtD
Ceftriaxone—Urticaria—Losartan—type 2 diabetes mellitus	9.18e-05	0.000638	CcSEcCtD
Ceftriaxone—Body temperature increased—Losartan—type 2 diabetes mellitus	9.14e-05	0.000634	CcSEcCtD
Ceftriaxone—Abdominal pain—Losartan—type 2 diabetes mellitus	9.14e-05	0.000634	CcSEcCtD
Ceftriaxone—Vomiting—Valsartan—type 2 diabetes mellitus	9.09e-05	0.000631	CcSEcCtD
Ceftriaxone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000628	CcSEcCtD
Ceftriaxone—Rash—Valsartan—type 2 diabetes mellitus	9.01e-05	0.000626	CcSEcCtD
Ceftriaxone—Dermatitis—Valsartan—type 2 diabetes mellitus	9e-05	0.000625	CcSEcCtD
Ceftriaxone—Vomiting—Orlistat—type 2 diabetes mellitus	8.98e-05	0.000623	CcSEcCtD
Ceftriaxone—Headache—Valsartan—type 2 diabetes mellitus	8.95e-05	0.000622	CcSEcCtD
Ceftriaxone—Diarrhoea—Metformin—type 2 diabetes mellitus	8.91e-05	0.000618	CcSEcCtD
Ceftriaxone—Rash—Orlistat—type 2 diabetes mellitus	8.91e-05	0.000618	CcSEcCtD
Ceftriaxone—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.9e-05	0.000618	CcSEcCtD
Ceftriaxone—Dermatitis—Orlistat—type 2 diabetes mellitus	8.9e-05	0.000618	CcSEcCtD
Ceftriaxone—Headache—Orlistat—type 2 diabetes mellitus	8.85e-05	0.000614	CcSEcCtD
Ceftriaxone—Cefazolin—ALB—type 2 diabetes mellitus	8.81e-05	0.0521	CrCbGaD
Ceftriaxone—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.73e-05	0.000606	CcSEcCtD
Ceftriaxone—Pruritus—Irbesartan—type 2 diabetes mellitus	8.69e-05	0.000603	CcSEcCtD
Ceftriaxone—Dizziness—Metformin—type 2 diabetes mellitus	8.61e-05	0.000598	CcSEcCtD
Ceftriaxone—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.52e-05	0.000591	CcSEcCtD
Ceftriaxone—Nausea—Valsartan—type 2 diabetes mellitus	8.49e-05	0.000589	CcSEcCtD
Ceftriaxone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.4e-05	0.000583	CcSEcCtD
Ceftriaxone—Nausea—Orlistat—type 2 diabetes mellitus	8.39e-05	0.000582	CcSEcCtD
Ceftriaxone—Vomiting—Metformin—type 2 diabetes mellitus	8.28e-05	0.000575	CcSEcCtD
Ceftriaxone—Rash—Metformin—type 2 diabetes mellitus	8.21e-05	0.00057	CcSEcCtD
Ceftriaxone—Dermatitis—Metformin—type 2 diabetes mellitus	8.2e-05	0.000569	CcSEcCtD
Ceftriaxone—Pruritus—Losartan—type 2 diabetes mellitus	8.18e-05	0.000568	CcSEcCtD
Ceftriaxone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.17e-05	0.000567	CcSEcCtD
Ceftriaxone—Headache—Metformin—type 2 diabetes mellitus	8.15e-05	0.000566	CcSEcCtD
Ceftriaxone—Dizziness—Irbesartan—type 2 diabetes mellitus	8.12e-05	0.000564	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.11e-05	0.000563	CcSEcCtD
Ceftriaxone—Diarrhoea—Losartan—type 2 diabetes mellitus	7.91e-05	0.000549	CcSEcCtD
Ceftriaxone—Urticaria—Ramipril—type 2 diabetes mellitus	7.87e-05	0.000547	CcSEcCtD
Ceftriaxone—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.84e-05	0.000544	CcSEcCtD
Ceftriaxone—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.84e-05	0.000544	CcSEcCtD
Ceftriaxone—Vomiting—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.000542	CcSEcCtD
Ceftriaxone—Rash—Irbesartan—type 2 diabetes mellitus	7.75e-05	0.000538	CcSEcCtD
Ceftriaxone—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.74e-05	0.000537	CcSEcCtD
Ceftriaxone—Nausea—Metformin—type 2 diabetes mellitus	7.73e-05	0.000537	CcSEcCtD
Ceftriaxone—Headache—Irbesartan—type 2 diabetes mellitus	7.7e-05	0.000534	CcSEcCtD
Ceftriaxone—Dizziness—Losartan—type 2 diabetes mellitus	7.64e-05	0.000531	CcSEcCtD
Ceftriaxone—Vomiting—Losartan—type 2 diabetes mellitus	7.35e-05	0.00051	CcSEcCtD
Ceftriaxone—Cefalotin—ALB—type 2 diabetes mellitus	7.31e-05	0.0433	CrCbGaD
Ceftriaxone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.3e-05	0.000507	CcSEcCtD
Ceftriaxone—Nausea—Irbesartan—type 2 diabetes mellitus	7.3e-05	0.000507	CcSEcCtD
Ceftriaxone—Rash—Losartan—type 2 diabetes mellitus	7.29e-05	0.000506	CcSEcCtD
Ceftriaxone—Dermatitis—Losartan—type 2 diabetes mellitus	7.28e-05	0.000506	CcSEcCtD
Ceftriaxone—Headache—Losartan—type 2 diabetes mellitus	7.24e-05	0.000503	CcSEcCtD
Ceftriaxone—Pruritus—Ramipril—type 2 diabetes mellitus	7.01e-05	0.000487	CcSEcCtD
Ceftriaxone—Nausea—Losartan—type 2 diabetes mellitus	6.87e-05	0.000477	CcSEcCtD
Ceftriaxone—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.78e-05	0.000471	CcSEcCtD
Ceftriaxone—Dizziness—Ramipril—type 2 diabetes mellitus	6.55e-05	0.000455	CcSEcCtD
Ceftriaxone—Vomiting—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000438	CcSEcCtD
Ceftriaxone—Rash—Ramipril—type 2 diabetes mellitus	6.25e-05	0.000434	CcSEcCtD
Ceftriaxone—Dermatitis—Ramipril—type 2 diabetes mellitus	6.24e-05	0.000434	CcSEcCtD
Ceftriaxone—Headache—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000431	CcSEcCtD
Ceftriaxone—Nausea—Ramipril—type 2 diabetes mellitus	5.89e-05	0.000409	CcSEcCtD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	3.09e-05	0.000546	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	3.09e-05	0.000546	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PTPN1—type 2 diabetes mellitus	3.09e-05	0.000545	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.08e-05	0.000543	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—LPL—type 2 diabetes mellitus	3.07e-05	0.000542	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.06e-05	0.00054	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—RASGRP1—type 2 diabetes mellitus	3.04e-05	0.000536	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—TNF—type 2 diabetes mellitus	3.03e-05	0.000535	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.03e-05	0.000535	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ADCY5—type 2 diabetes mellitus	3.01e-05	0.000531	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GPX1—type 2 diabetes mellitus	3e-05	0.000529	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—RELA—type 2 diabetes mellitus	2.99e-05	0.000528	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.95e-05	0.000521	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.93e-05	0.000518	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CD36—type 2 diabetes mellitus	2.92e-05	0.000515	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—PTGS2—type 2 diabetes mellitus	2.9e-05	0.000513	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.9e-05	0.000511	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.88e-05	0.000509	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PPP2CA—type 2 diabetes mellitus	2.88e-05	0.000509	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ATP2A3—type 2 diabetes mellitus	2.85e-05	0.000502	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.83e-05	0.000499	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.82e-05	0.000498	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.82e-05	0.000498	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	2.8e-05	0.000495	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—MTHFR—type 2 diabetes mellitus	2.77e-05	0.000488	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.76e-05	0.000488	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	2.76e-05	0.000486	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SOD1—type 2 diabetes mellitus	2.75e-05	0.000485	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.74e-05	0.000484	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.74e-05	0.000483	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.72e-05	0.000481	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.71e-05	0.000479	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.71e-05	0.000479	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PPARA—type 2 diabetes mellitus	2.71e-05	0.000479	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.71e-05	0.000478	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.71e-05	0.000478	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.7e-05	0.000476	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	2.69e-05	0.000474	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.67e-05	0.000471	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.66e-05	0.00047	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—GNB3—type 2 diabetes mellitus	2.66e-05	0.000469	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.65e-05	0.000467	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—AGT—type 2 diabetes mellitus	2.63e-05	0.000464	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—IGF2—type 2 diabetes mellitus	2.61e-05	0.000461	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.61e-05	0.00046	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CALM1—type 2 diabetes mellitus	2.58e-05	0.000456	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—APOE—type 2 diabetes mellitus	2.57e-05	0.000454	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—APOA1—type 2 diabetes mellitus	2.54e-05	0.000449	CbGpPWpGaD
Ceftriaxone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	2.54e-05	0.000449	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	2.52e-05	0.000445	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.5e-05	0.000441	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.47e-05	0.000437	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—VEGFA—type 2 diabetes mellitus	2.47e-05	0.000436	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TNF—type 2 diabetes mellitus	2.47e-05	0.000436	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	2.46e-05	0.000435	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IL6—type 2 diabetes mellitus	2.45e-05	0.000432	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.44e-05	0.00043	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—THBD—type 2 diabetes mellitus	2.42e-05	0.000427	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—type 2 diabetes mellitus	2.35e-05	0.000415	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	2.34e-05	0.000414	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	2.34e-05	0.000414	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.32e-05	0.000409	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	2.31e-05	0.000407	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	2.3e-05	0.000407	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—CD36—type 2 diabetes mellitus	2.3e-05	0.000406	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—BHMT—type 2 diabetes mellitus	2.3e-05	0.000406	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.28e-05	0.000403	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.27e-05	0.000401	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—TGFB1—type 2 diabetes mellitus	2.27e-05	0.0004	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.25e-05	0.000397	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PPARG—type 2 diabetes mellitus	2.24e-05	0.000396	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	2.23e-05	0.000393	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.2e-05	0.000388	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—INS—type 2 diabetes mellitus	2.2e-05	0.000388	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.18e-05	0.000384	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—type 2 diabetes mellitus	2.16e-05	0.000381	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.14e-05	0.000378	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	2.14e-05	0.000377	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.06e-05	0.000364	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ATP2A2—type 2 diabetes mellitus	2.05e-05	0.000361	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—CALM1—type 2 diabetes mellitus	2.04e-05	0.000359	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.03e-05	0.000359	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ALB—type 2 diabetes mellitus	2.02e-05	0.000356	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AANAT—type 2 diabetes mellitus	2.01e-05	0.000355	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTGDS—type 2 diabetes mellitus	2.01e-05	0.000355	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—APOA1—type 2 diabetes mellitus	2.01e-05	0.000354	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL6—type 2 diabetes mellitus	1.99e-05	0.000352	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TRPC6—type 2 diabetes mellitus	1.98e-05	0.00035	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.98e-05	0.00035	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	1.96e-05	0.000346	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—F7—type 2 diabetes mellitus	1.95e-05	0.000344	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3R1—type 2 diabetes mellitus	1.93e-05	0.00034	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—NOS3—type 2 diabetes mellitus	1.93e-05	0.00034	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PRKCB—type 2 diabetes mellitus	1.91e-05	0.000338	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.91e-05	0.000337	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPD2—type 2 diabetes mellitus	1.9e-05	0.000336	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CDO1—type 2 diabetes mellitus	1.9e-05	0.000336	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.86e-05	0.000329	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.85e-05	0.000327	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.85e-05	0.000327	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.84e-05	0.000324	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.84e-05	0.000324	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AK1—type 2 diabetes mellitus	1.82e-05	0.000321	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.8e-05	0.000317	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.77e-05	0.000312	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.77e-05	0.000312	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PTGS2—type 2 diabetes mellitus	1.76e-05	0.000311	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ADRA2A—type 2 diabetes mellitus	1.75e-05	0.000308	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLAT—type 2 diabetes mellitus	1.74e-05	0.000307	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TIMP1—type 2 diabetes mellitus	1.74e-05	0.000307	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.73e-05	0.000305	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.72e-05	0.000304	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.72e-05	0.000303	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.71e-05	0.000301	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC5A4—type 2 diabetes mellitus	1.68e-05	0.000296	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—MAT1A—type 2 diabetes mellitus	1.68e-05	0.000296	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—IGF1—type 2 diabetes mellitus	1.68e-05	0.000296	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—AKT2—type 2 diabetes mellitus	1.68e-05	0.000296	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.67e-05	0.000295	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.64e-05	0.000289	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS1—type 2 diabetes mellitus	1.63e-05	0.000289	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.63e-05	0.000289	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.62e-05	0.000287	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—G6PC—type 2 diabetes mellitus	1.62e-05	0.000286	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HBA2—type 2 diabetes mellitus	1.62e-05	0.000286	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.62e-05	0.000286	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ND1—type 2 diabetes mellitus	1.62e-05	0.000286	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ENPP1—type 2 diabetes mellitus	1.62e-05	0.000286	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SERPINE1—type 2 diabetes mellitus	1.59e-05	0.000281	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PTPN1—type 2 diabetes mellitus	1.59e-05	0.000281	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	1.58e-05	0.000279	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GCGR—type 2 diabetes mellitus	1.57e-05	0.000277	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—RASGRP1—type 2 diabetes mellitus	1.56e-05	0.000276	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3R1—type 2 diabetes mellitus	1.52e-05	0.000268	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.51e-05	0.000267	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.51e-05	0.000266	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—OXCT1—type 2 diabetes mellitus	1.48e-05	0.000261	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYTB—type 2 diabetes mellitus	1.48e-05	0.000261	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SRD5A1—type 2 diabetes mellitus	1.44e-05	0.000255	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.44e-05	0.000253	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SOD1—type 2 diabetes mellitus	1.42e-05	0.00025	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HSD17B3—type 2 diabetes mellitus	1.38e-05	0.000243	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—STAR—type 2 diabetes mellitus	1.38e-05	0.000243	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ACACA—type 2 diabetes mellitus	1.38e-05	0.000243	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.38e-05	0.000243	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—GNB3—type 2 diabetes mellitus	1.37e-05	0.000242	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.36e-05	0.000241	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IGF2—type 2 diabetes mellitus	1.35e-05	0.000238	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	1.32e-05	0.000233	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CBS—type 2 diabetes mellitus	1.32e-05	0.000233	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—APOB—type 2 diabetes mellitus	1.31e-05	0.000231	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	1.27e-05	0.000224	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—COX2—type 2 diabetes mellitus	1.27e-05	0.000224	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	1.25e-05	0.00022	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.25e-05	0.00022	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	1.23e-05	0.000217	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—UCP3—type 2 diabetes mellitus	1.23e-05	0.000217	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—UCP2—type 2 diabetes mellitus	1.23e-05	0.000217	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.19e-05	0.00021	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.19e-05	0.000209	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CD36—type 2 diabetes mellitus	1.19e-05	0.000209	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.18e-05	0.000208	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	1.17e-05	0.000207	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.17e-05	0.000207	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PCK1—type 2 diabetes mellitus	1.15e-05	0.000204	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.14e-05	0.000201	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.13e-05	0.0002	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	1.12e-05	0.000198	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.11e-05	0.000196	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	1.1e-05	0.000193	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	1.08e-05	0.000191	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HK1—type 2 diabetes mellitus	1.08e-05	0.000191	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.08e-05	0.000191	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.06e-05	0.000187	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	1.05e-05	0.000185	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	1.04e-05	0.000184	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	1.04e-05	0.000184	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LPA—type 2 diabetes mellitus	1.04e-05	0.000184	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GCKR—type 2 diabetes mellitus	1.04e-05	0.000184	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	1.03e-05	0.000183	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	1.01e-05	0.000177	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1e-05	0.000177	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	1e-05	0.000177	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	9.87e-06	0.000174	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	9.75e-06	0.000172	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	9.72e-06	0.000172	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	9.54e-06	0.000168	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.52e-06	0.000168	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.41e-06	0.000166	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	9.3e-06	0.000164	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.95e-06	0.000158	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—AKT1—type 2 diabetes mellitus	8.87e-06	0.000156	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	8.69e-06	0.000153	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	8.64e-06	0.000153	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	8.64e-06	0.000152	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	8.51e-06	0.00015	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—MTR—type 2 diabetes mellitus	8.51e-06	0.00015	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	8.34e-06	0.000147	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.3e-06	0.000146	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LIPC—type 2 diabetes mellitus	8.29e-06	0.000146	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HBA1—type 2 diabetes mellitus	8.29e-06	0.000146	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GCK—type 2 diabetes mellitus	8.29e-06	0.000146	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	8.24e-06	0.000145	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	8.21e-06	0.000145	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	8.09e-06	0.000143	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CETP—type 2 diabetes mellitus	8e-06	0.000141	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	7.84e-06	0.000138	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	7.84e-06	0.000138	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	7.44e-06	0.000131	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	7.44e-06	0.000131	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	7.44e-06	0.000131	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CTGF—type 2 diabetes mellitus	7.3e-06	0.000129	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	7.23e-06	0.000128	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.13e-06	0.000126	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	7.08e-06	0.000125	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	6.99e-06	0.000123	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	6.8e-06	0.00012	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	6.73e-06	0.000119	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	6.73e-06	0.000119	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	6.56e-06	0.000116	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.53e-06	0.000115	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GCG—type 2 diabetes mellitus	6.45e-06	0.000114	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	6.45e-06	0.000114	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SRC—type 2 diabetes mellitus	5.8e-06	0.000102	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	5.65e-06	9.97e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GNB3—type 2 diabetes mellitus	5.56e-06	9.81e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.56e-06	9.81e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	5.53e-06	9.76e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CAT—type 2 diabetes mellitus	5.46e-06	9.63e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOB—type 2 diabetes mellitus	5.3e-06	9.35e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	5.18e-06	9.15e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	5.16e-06	9.1e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LPL—type 2 diabetes mellitus	5.06e-06	8.93e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	4.95e-06	8.74e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPX1—type 2 diabetes mellitus	4.94e-06	8.71e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CD36—type 2 diabetes mellitus	4.81e-06	8.49e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	4.75e-06	8.38e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	4.56e-06	8.04e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPARA—type 2 diabetes mellitus	4.47e-06	7.89e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AGT—type 2 diabetes mellitus	4.33e-06	7.64e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CALM1—type 2 diabetes mellitus	4.26e-06	7.51e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOE—type 2 diabetes mellitus	4.24e-06	7.49e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOA1—type 2 diabetes mellitus	4.19e-06	7.4e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPARG—type 2 diabetes mellitus	3.69e-06	6.52e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—INS—type 2 diabetes mellitus	3.62e-06	6.4e-05	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	3.6e-06	6.36e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	3.18e-06	5.61e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NOS3—type 2 diabetes mellitus	3.18e-06	5.61e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.91e-06	5.13e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.46e-06	2.58e-05	CbGpPWpGaD
